Jan W. F. Wasley - Concepedia

Concepedia

Author

Jan W. F. Wasley

Novartis (Switzerland)

Also Known As

J W Wasley, J. W. F. WASLEY, J. W. F. Wasley, J. Wasley, J.W.F. Wasley, Jan W. F. Wasley, Jan W.F Wasley, Jan W.F. Wasley, Jan Wasley

68

Publications

1.3K

Citations

20

H-Index

45

Concepts

All Affiliations

Novartis (Switzerland)Repligen (United States)Nivalis Therapeutics (United States)Wren Laboratories (United States)

JW

About

Jan W. F. Wasley is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	743
2	Natural Sciences	12	14	432
3	Engineering	4	4	102
4	Humanities	1	1	31
5	Social Sciences	1	1	35

Jan W. F. Wasley

×

32

Publications

1.3K

Citations

20

H-Index

	Year	Citations
Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist Robert Neale, Scott Fallon, William C. Boyar, European Journal of Pharmacology Molecular PharmacologyPharmacological CharacterizationBiochemistryFunctional SelectivityMedicine	1987	160
.beta.-Lapachone: synthesis of derivatives and activities in tumor models K. SCHAFFNER‐SABBA, K. H. Schmidt-Ruppin, W. Wehrli, Journal of Medicinal Chemistry Medicinal ChemistryAnalogous CompoundsDerivativesBiochemistryMedicine	1984	114
CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity. Jon Norman, Justin Ansell, George A. Stone, Molecular Pharmacology	1987	109
Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors Neville F. Ford, Leslie J. Browne, Thomas Campbell, Journal of Medicinal Chemistry	1985	106
NGB 2904 and NGB 2849: Two highly selective dopamine D3 receptor antagonists Jun Yuan, Xi Chen, Robbin Brodbeck, Bioorganic & Medicinal Chemistry Letters Ngb 2849Molecular PharmacologyFunctional SelectivityMedicineNeuropharmacology	1998	75
2-Phenyl-4(5)-[[4-(pyrimidin-2- yl)piperazin-1-yl]methyl]imidazole. A Highly Selective Antagonist at Cloned Human D<sub>4</sub> Receptors Andrew Thurkauf, Jun Yuan, Xi Chen, Journal of Medicinal Chemistry Highly Selective AntagonistDrug TargetAltmetric Attention ScorePharmacotherapyPharmaceutical Chemistry	1997	58
Discovery of <i>S</i>-Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases Xicheng Sun, Jan W. F. Wasley, Jian Qiu, ACS Medicinal Chemistry Letters AsthmaInflammatory Lung DiseaseLung InflammationNitric OxideImmunology	2011	57
Indoline and piperazine containing derivatives as a novel class of mixed D2/D4 receptor antagonists. Part 2: Asymmetric synthesis and biological evaluation He Zhao, Xiao‐Shu He, Andrew Thurkauf, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDerivative (Chemistry)DerivativesBiochemistryMedicine	2002	56
STRUCTURES OF CHLOROBIUM CHLOROPHYLLS (660) A. S. Holt, J. W. Purdie, Jan W. F. Wasley Canadian Journal of Chemistry Inorganic ChemistryCrystal StructureChlorobium ChlorophyllsBioorganic ChemistryEngineering	1966	53
<i>trans</i>-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: Mixed Dopamine D<sub>2</sub>/D<sub>4</sub> Receptor Antagonists as Potential Antipsychotic Agents Xiaoyan Zhang, Kevin J. Hodgetts, He Zhao, Journal of Medicinal Chemistry	2000	36

Page 1